OIL AND GAS

FOOD AND FIBRE

ENVIRONMENT

Health

 

HEALTH

RESEARCH AND
POST-SECONDARY
PROGRAMS

TECHNOLOGY
COMMERCIALIZATION
SERVICES AND FUNDING

OUR TEAMS

PARTNERSHIPS

Nano med-lab shrinks time and costs
 
The plastic diagnostic chip in the Domino system can perform 20 genetic tests from a single drop of blood.

Client

Aquila Diagnostic Systems

 

Opportunity

Shrink a medical lab to the size of a toaster.

Provide test results in minutes, instead of days.

Reduce health care costs, medical guesswork and indiscriminate use of antibiotics.

Aquila Diagnostic Systems, based in Edmonton, is poised to revolutionize human and animal health care with its precise and prompt, lab-in-a-box, Domino.

The desktop technology promises to empower doctors, veterinarians and livestock producers with on-site, under-an hour analysis of a subject’s genetic characteristics or infectious illness.

Domino’s pioneering research began at the University of Alberta, supported by a $5 million award from Alberta Innovates-Health Solutions. The research team then created a spinoff company, Aquila, which found commercialization support from Alberta Innovates-Technology Futures.

Alberta wants to build research and commercial capacity in the priority area of nanotechnology. Technology Futures helps achieve this goal through its nanoAlberta team and related program, nanoBridge. Aquila received an Innovation Voucher to help fund its intellectual property work. It also received business advice from nanoWorks and in 2012 was awarded the NanoVenture Prize sponsored by Technology Futures. Aquila is currently receiving funding support through the Industry r&D Associates program.

This financial and business support will help Aquila enter the marketplace. The company will first introduce Domino to Alberta’s feedlots, where current livestock testing requires shipping of samples to a distant lab. Aquila’s plan is to prove its technology on livestock, then progress into applications related to human health.

 

Status

Domino can perform 20 genetic tests from a single drop of blood on a disposable, postage-stamp-sized plastic chip with reaction compartments measuring one-billionth of a litre, or nanolitre, in size.

The technology can detect blood-borne illness, or provide genetic profiling to help determine optimal drug regimens
for the treatment of diseases like cancer.

Aquila serves as an example of how Alberta’s innovation system works to guide new and exciting ideas from lab-based research to the marketplace. It is one example of the results being achieved in support of economic diversification in Alberta.

To see more stories and videos, visit our Success Stories Map.

 

Put our expertise to work for you

 

Related Links

Marlene Huerta    Aquila Diagnostic Systems

Alberta Innovates-Technology Futures

   
780-450-5034    
marlene.huerta@albertainnovates.ca